These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 11734615)
21. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system. Lambert PD; Gross R; Nemeroff CB; Kilts CD Ann N Y Acad Sci; 1995 May; 757():377-89. PubMed ID: 7611695 [No Abstract] [Full Text] [Related]
22. d-Amphetamine-induced increase in neurotensin and neuropeptide Y outflow in the ventral striatum is mediated via stimulation of dopamine D1 and D2/3 receptors. Gruber SH; Nomikos GG; Mathé AA J Neurosci Res; 2002 Jul; 69(1):133-9. PubMed ID: 12111825 [TBL] [Abstract][Full Text] [Related]
23. Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides. Ferraro L; Tomasini MC; Fuxe K; Agnati LF; Mazza R; Tanganelli S; Antonelli T Brain Res Rev; 2007 Aug; 55(1):144-54. PubMed ID: 17448541 [TBL] [Abstract][Full Text] [Related]
24. Interactions of neurotensin with dopamine-containing neurons in the central nervous system. Ervin GN; Nemeroff CB Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12 Suppl():S53-69. PubMed ID: 3074341 [TBL] [Abstract][Full Text] [Related]
25. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. Kitabgi P Curr Opin Drug Discov Devel; 2002 Sep; 5(5):764-76. PubMed ID: 12630297 [TBL] [Abstract][Full Text] [Related]
26. Differential response of neurotensin to methamphetamine self-administration. Frankel PS; Hoonakker AJ; Hanson GR Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855 [TBL] [Abstract][Full Text] [Related]
28. Neurotensin and growth of normal and neoplastic tissues. Evers BM Peptides; 2006 Oct; 27(10):2424-33. PubMed ID: 16904238 [TBL] [Abstract][Full Text] [Related]
29. [Neurotensin, dopamine and mode of action of neuroleptics]. Tassin JP Encephale; 1989; 15(5):465-70. PubMed ID: 2574102 [TBL] [Abstract][Full Text] [Related]
30. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders. Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308 [TBL] [Abstract][Full Text] [Related]
31. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain. Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313 [TBL] [Abstract][Full Text] [Related]
32. Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. Martorana A; Martella G; D'Angelo V; Fusco FR; Spadoni F; Bernardi G; Stefani A Synapse; 2006 Oct; 60(5):371-83. PubMed ID: 16838364 [TBL] [Abstract][Full Text] [Related]
33. Receptor-receptor interactions and their relevance for receptor diversity. Focus on neuropeptide/dopamine interactions. Fuxe K; Li XM; Tanganelli S; Hedlund P; O'Connor WT; Ferraro L; Ungerstedt U; Agnati LF Ann N Y Acad Sci; 1995 May; 757():365-76. PubMed ID: 7611694 [TBL] [Abstract][Full Text] [Related]
34. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice. Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157 [TBL] [Abstract][Full Text] [Related]
36. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Miczek KA; Fish EW; De Bold JF; De Almeida RM Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636 [TBL] [Abstract][Full Text] [Related]
39. [Effects of neurotensin microinjected into ventral tegmental area on spontaneous motor activity in neonatal 6-hydroxydopamine-treated rats]. Ikegami M; Iwasaki T Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):83-5. PubMed ID: 15164616 [TBL] [Abstract][Full Text] [Related]
40. The electrophysiological actions of neurotensin in the central nervous system. Stowe ZN; Nemeroff CB Life Sci; 1991; 49(14):987-1002. PubMed ID: 1890928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]